How Male-Focused STI Testing Models Fail Women

Sexual health in the United States has long been shaped by the needs of men who have sex with men. There are good reasons for this. Gay and bisexual men have historically been underserved by the medical system and have been disproportionately impacted by sexually transmitted infections, especially HIV and AIDS. They deserved targeted resources, specialized clinics, proactive testing, and culturally competent care — and they still do.

This focus led to enormous progress. LGBTQ-focused clinics save lives, prevent infections, and provide affirming, stigma-free care that many patients cannot find anywhere else. None of this article is a criticism of those clinics or the people they serve.

But there is a side effect that almost no one talks about: the STI testing model built for gay men does not translate well to the needs of women.

Many women turn to LGBTQ-focused clinics because they are welcoming, inclusive, and nonjudgmental. That is a wonderful thing. But being inclusive and being clinically optimized for women are two different things. Women have different anatomy, different reservoirs of infection, different patterns of sexual exposure, and different long-term health risks. When women are tested using protocols built around gay-male epidemiology, important infections can be missed.

⸻

What Is a “Gay-Male-Focused” Public Health Center?

This is not a political label. It is an epidemiological one.

A “gay-male-focused” sexual-health center is any clinic whose core mission and testing protocols were shaped by the HIV epidemic among MSM populations. These are typically:

• clinics offering taxpayer-funded or low-cost STI testing
• clinics built around PrEP access
• LGBTQ community health centers
• organizations primarily focused on HIV and syphilis prevention

These clinics are essential. They provide culturally competent care, reduce stigma, and reach populations that were ignored for decades. They serve their patients exceptionally well.

But their protocols reflect the infections that matter most in MSM populations:

• HIV
• syphilis
• gonorrhea and chlamydia

These testing patterns make sense for the populations they were designed to protect. But they do not map cleanly onto the risks women face.

⸻

The Biggest Blind Spot: Mycoplasma Genitalium Hurts Women Far More

Mycoplasma genitalium (Mgen) is one of the most underdiagnosed STIs in the United States — and one of the most damaging for women. LGBTQ-focused clinics rarely include it in standard testing because historically it has not been a major infection within MSM communities.

But for women, the consequences of missing Mgen can be serious and long-lasting.

Mgen is associated with:

• pelvic inflammatory disease
• recurrent cervicitis
• infertility
• chronic pelvic pain
• endometritis
• inflammation of reproductive tissue
• pregnancy complications

Despite these risks, most women with symptoms are never tested for Mgen. The testing model they encounter simply was not designed with their biology or complications in mind.

This is not intentional neglect.

It is protocol inheritance — using a model created for one population to care for another.

⸻

A Major Blind Spot: Trichomoniasis Hits Women Hardest

Trichomoniasis is one of the most common STIs in the country, yet one of the most overlooked — especially for women. It is often dismissed as a “minor” infection, but for women it can lead to real health problems.

Trichomoniasis in women is linked to:

• persistent vaginal and cervical inflammation
• pain or discomfort during sex
• increased risk of acquiring other STIs
• vaginal discharge and odor that can last for years
• pregnancy complications, including preterm birth
• and emerging research suggests a possible increased risk of cervical cancer due to chronic inflammation

Men often carry trichomoniasis silently.

Women rarely do.

For women, trich can smolder quietly for months or years, causing ongoing inflammation of the vaginal and cervical tissue. That chronic inflammation is what increases susceptibility to other infections and may contribute to longer-term cellular changes.

Despite this, trichomoniasis is frequently left out of the standard STI panel at clinics built around gay-male risk patterns. Not because anyone intends harm, but because trich is simply not a major clinical issue within MSM populations. The testing system evolved to detect the infections most relevant to gay men — not the ones most relevant to women.

A woman can walk out with a “negative” STI result that never even looked for the infection most likely to be affecting her.

⸻

Why This Matters for Women

Women deserve STI testing based on their own biology, their own risks, and their own long-term health outcomes — not someone else’s.

Women need:

• testing based on their actual exposure sites
• cervical and vaginal testing
• pharyngeal testing when oral exposure is present
• trichomoniasis testing when indicated
• Mgen testing when symptomatic
• transparent explanations of what is and is not included
• sexual-health education designed specifically for women

When a woman receives testing optimized for MSM epidemiology, she gets incomplete care — even if the clinic is inclusive and caring.

This is not about reducing care for gay men.

It is about ensuring women receive equally appropriate, accurate, and comprehensive sexual-health care.

⸻

The Bottom Line

LGBTQ-focused clinics are essential and lifesaving. They provide dignity, access, and safety for millions. But the STI testing model they pioneered was designed for a specific population with specific risks — not for women.

Women deserve testing that reflects their own anatomy, their own risks, and their own long-term health needs.

At Shameless Care, we test according to exposure site, gender-specific epidemiology, and the infections most relevant to women — including the ones most clinics overlook.

Women deserve sexual-health care that sees them clearly.

Not as an afterthought.

Not as an adaptation.

But as a population with their own biology, risks, and priorities.